Overview
Samuel Amintas practices practicing medicine in Pessac-sur-dordogne, France.
Mr. Amintas is highly rated in 1 condition, according to our data. His clinical expertise encompasses Lipogranulomatosis, Myoclonic Epilepsy, Marginal Zone Lymphoma (MZL), and Primary Lateral Sclerosis.
He is actively involved in clinical research, co-authoring 36 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Samuel Amintas
Is Samuel Amintas a top-rated expert for Lipogranulomatosis?
MediFind is an objective health platform that identifies experts based on real-world data. Samuel Amintas is classified as an Advanced expert for Lipogranulomatosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Samuel Amintas participate in research or clinical trials?
Yes. Samuel Amintas has published 36 articles and abstracts on conditions like Lipogranulomatosis. You can view a list of Samuel Amintas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- LipogranulomatosisMr. Amintas isAdvanced. Learn about Lipogranulomatosis.
- Experienced
- Alpha-1 Antitrypsin Deficiency (AATD)Mr. Amintas isExperienced. Learn about Alpha-1 Antitrypsin Deficiency (AATD).
- Colorectal CancerMr. Amintas isExperienced. Learn about Colorectal Cancer.
- Dentatorubral-Pallidoluysian AtrophyMr. Amintas isExperienced. Learn about Dentatorubral-Pallidoluysian Atrophy.
- ErythrodermaMr. Amintas isExperienced. Learn about Erythroderma.
- Exfoliative DermatitisMr. Amintas isExperienced. Learn about Exfoliative Dermatitis.
- Farber LipogranulomatosisMr. Amintas isExperienced. Learn about Farber Lipogranulomatosis.
- Lafora DiseaseMr. Amintas isExperienced. Learn about Lafora Disease.
- Marginal Zone Lymphoma (MZL)Mr. Amintas isExperienced. Learn about Marginal Zone Lymphoma (MZL).
- Myoclonic EpilepsyMr. Amintas isExperienced. Learn about Myoclonic Epilepsy.
- Non-Hodgkin LymphomaMr. Amintas isExperienced. Learn about Non-Hodgkin Lymphoma.
- Pancreatic CancerMr. Amintas isExperienced. Learn about Pancreatic Cancer.
- Pancreatic Ductal AdenocarcinomaMr. Amintas isExperienced. Learn about Pancreatic Ductal Adenocarcinoma.
- PorphyriaMr. Amintas isExperienced. Learn about Porphyria.
- Primary Lateral SclerosisMr. Amintas isExperienced. Learn about Primary Lateral Sclerosis.
- Sezary SyndromeMr. Amintas isExperienced. Learn about Sezary Syndrome.
- Subcutaneous EmphysemaMr. Amintas isExperienced. Learn about Subcutaneous Emphysema.